For the Quarter Ending December 2022
In the North American region, the price of Dexamethasone Sodium Phosphate fluctuated throughout the fourth quarter of 2022. According to the data, the prices of Dexamethasone Sodium Phosphate first inclined in October and then further in November as a result of limited inventories of products among domestic retailers coupled with high demand from downstream pharmaceutical and healthcare industries. Moving towards December, the prices started to follow a downward trajectory as market sources revealed that because of low offtakes for the product from regional buyers, traders got an opportunity to lower their prices. As a result, the prices of Dexamethasone Sodium Phosphate decreased with the settlement at USD 894650/MT in the United States by the end of the third quarter.
Across the Asia-Pacific region, Dexamethasone Sodium Phosphate prices followed an upward trajectory in the first two months and began to decrease in early December 2022. In China, prices for Dexamethasone Sodium Phosphate demonstrated a rise of a total of 3.6% from 1st October to 30th November. As more COVID-19 instances caused disruptions, China's industrial activity, a key engine of the country's economic growth, began to deteriorate. Though, this caused a lack of supply amongst local manufacturers. After that, prices for Dexamethasone Sodium Phosphate began to decline in early December, being held back by a rise in domestic inventory levels accompanied by a decline in international demand. The end-user pharmaceutical market had a general trading environment, and the overall manufacturing of the product was primarily based on demand. Moreover, the worsened Covid-19 outbreak weakened transport activities, and the weak market dynamics pressed down the prices. With this, the price of Dexamethasone Sodium Phosphate settled at USD 875650/MT FOB Shanghai in China.
Major European countries like Germany started facing similar market fundamentals to that of the Asia-Pacific region, where Dexamethasone Sodium Phosphate prices were risen by a considerable fraction during the fourth quarter of 2022. The data shows a rise of around 5.5% for Germany by the first half of November 2022, supported by high offtakes from the downstream pharmaceutical and healthcare industries. However, inadequate inventories among German traders due to limited imports from China amid Covid-19 protocols propelled buyers to search for every possible stock in the market. Later, Dexamethasone Sodium Phosphate changed its pricing dynamics during December as supply chain disruption subsided in response to a decline in orders. However, end-user players mainly hold uncertain buying interests amid weak demand, resulting in a bearish market outlook. Thus, by the quarter ending December, prices were assessed at USD 918740/MT in Germany.
For the Quarter Ending September 2022
During the first half of Q3, the price trend of Dexamethasone Sodium Phosphate inclined significantly by 2.7%, with a buoyant market sentiment in the North American region. The price surged to USD 911550/MT was supported by higher downstream demand and inquiries from the domestic market. Moving towards the second half of Q3, the prices started to follow a downward trajectory backed by an accumulation of inventories with local vendors. Eliminating the lockdown and resumption of production activities in the exporting countries kept the trading momentum firm in the US market. Overall, by the end of the third quarter, prices decreased with the settlement of USD 896730/MT CFR Los Houston in the United States.
In the APAC region, the prices of Dexamethasone Sodium Phosphate witnessed mixed sentiments during the third quarter of 2022. During the H1 of Q3, the prices rose considerably at a stable rate owing to consistent demand from end-user pharmaceutical sectors and weakened inventories with the domestic market participants. Furthermore, the halt in production activities and port congestion led to accumulated shipments which supported the pricing tendency in the market. However, the prices declined by 3.8% following the H2 of Q3 as factories resumed production, resulting in enough inventories among manufacturers to meet the overall demand. With this, the price of Dexamethasone Sodium Phosphate settled at USD 870655/MT FOB Shanghai in China.
During the third quarter of 2022, Dexamethasone Sodium Phosphate showcased fluctuations in the price trend in the European region. A glimpse of beneficial market sentiments was flashed with a 4.6% leap in price in the H2 of Q3 on account of increased demand from the pharmaceutical and healthcare industries. By the second half of the quarter, feeble purchasing activities were observed due to lowering demand from the regional market, resulting in the price decline of Dexamethasone Sodium Phosphate. Domestic merchants were pessimist about the existing stock, due to which they lowered the prices in the German domestic market to increase their orders. As a ripple effect in Germany, the CFR Hamburg prices of Dexamethasone Sodium Phosphate settled at USD 904730/MT in September 2022.
In the North American region, the Dexamethasone Sodium Phosphate API market showcased an upward trend due to favorable sentiments in the regional market during the second quarter of 2022. As Dexamethasone Sodium Phosphate API was imported from China, prices surged amidst the lockdown curb. In addition, supply constraints influenced by prolonged port congestion impacted the market in the United States. The value of Dexamethasone Sodium Phosphate was affected by high container freight expenses for import. The demand for Dexamethasone Sodium Phosphate API from the pharmaceutical sector increased. In the United States, the CFR price of Dexamethasone Sodium Phosphate inclined by 2.4% this quarter, with values assessed at USD 887130/MT.
In Q2 2022, the Dexamethasone Sodium Phosphate API market witnessed positive market sentiments in Asia. The price of Dexamethasone Sodium Phosphate API followed an upward trajectory throughout the quarter. The enhancement in API price was due to strong demand and low inventories from the pharmaceutical sector. Due to limited supply, high production rates in major API manufacturing plants resulted in a spike in the cost of Dexamethasone Sodium Phosphate. In the Asia Pacific region, the price of Dexamethasone Sodium Phosphate in India settled at INR 55564750/MT Ex-Vapi with a quarterly inclination of 13.8%, whereas in China, the FOB price inclined by 3.3%, with values assessing at USD 892676/MT.
The Dexamethasone Sodium Phosphate API market climbed moderately in the European region during the second quarter of 2022 due to consistent offtakes from the downstream pharmaceutical sectors. In Europe, Germany showcased a soared behavior towards the Dexamethasone Sodium Phosphate API market due to increased raw material prices. The regional DSP cost has escalated due to rising energy and crude oil prices and the geopolitical conflict between Russia and Ukraine. In addition, rising production costs, rerouting of transportation, and a cargo scarcity that increased freight costs all affected API pricing in the market. This quarter saw a 3.1% increase in Dexamethasone Sodium Phosphate prices in Germany, with values assembling at USD 878320/MT in June.